0001127602-22-004991.txt : 20220215
0001127602-22-004991.hdr.sgml : 20220215
20220215161633
ACCESSION NUMBER: 0001127602-22-004991
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220212
FILED AS OF DATE: 20220215
DATE AS OF CHANGE: 20220215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gregory Ginger
CENTRAL INDEX KEY: 0001545716
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19311
FILM NUMBER: 22639368
MAIL ADDRESS:
STREET 1: C/O BIOGEN INC.
STREET 2: 225 BINNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOGEN INC.
CENTRAL INDEX KEY: 0000875045
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330112644
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 7814642000
MAIL ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC.
DATE OF NAME CHANGE: 20070427
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC
DATE OF NAME CHANGE: 20031112
FORMER COMPANY:
FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE
DATE OF NAME CHANGE: 19970530
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-12
0000875045
BIOGEN INC.
BIIB
0001545716
Gregory Ginger
BIOGEN INC.
225 BINNEY ST.
CAMBRIDGE
MA
02142
1
EVP, Human Resources
Common Stock
2022-02-12
4
M
0
793
0
A
10820.6165
D
Common Stock
2022-02-12
4
F
0
278
214.59
D
10542.6165
D
Common Stock
2022-02-12
4
M
0
879
0
A
11421.6165
D
Common Stock
2022-02-12
4
F
0
390
214.59
D
11031.6165
D
Common Stock
2022-02-12
4
F
0
584
214.59
D
10447.6165
D
Restricted Stock Unit
0
2022-02-12
4
M
0
793
0
D
2022-02-12
Common Stock
793
1505
D
Restricted Stock Unit
0
2022-02-12
4
J
0
1505
0
D
2022-02-12
Common Stock
1505
0
D
Restricted Stock Unit
0
2022-02-12
4
M
0
879
0
D
2023-02-12
Common Stock
879
4149
D
Restricted Stock Unit
0
2022-02-12
4
J
0
1633
0
D
2023-02-12
Common Stock
1633
2516
D
Represents shares withheld to satisfy the withholding tax liability due upon the vesting of shares, as previously disclosed by reporting person on January 21, 2022.
The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).
This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.
/s/ Wendell Taylor, attorney in fact for Ginger Gregory
2022-02-15